Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Latin America molecular diagnostics market was valued at USD 2.74 Billion in 2025 and is expected to grow at a CAGR of 8.10%, reaching USD 5.97 Billion by 2035. The market growth is supported by the increasing awareness of molecular testing benefits, improvements in diagnostic infrastructure, and expanding applications across multiple disease areas. The growing focus on precision medicine and preventive healthcare is expected to increase the adoption of genomic and molecular tests and sustain market growth.
Compound Annual Growth Rate
8.1%
Value in USD Billion
2026-2035
Read more about this report - Request a Free Sample
Molecular diagnostics is increasingly integrated into healthcare because of its ability to support accurate disease identification and provide clinically relevant molecular information. Developments in testing technologies are broadening its applications and improving the role of molecular analysis in diagnosis and patient care. The market was valued at USD 2.74 Billion in 2025. Across Latin America, demand for molecular diagnostics is being influenced by the growing need for accurate diagnostic solutions and advances in healthcare delivery. Increased use of molecular tests, improved laboratory infrastructure, and technological developments are supporting the market. The expanding application of these technologies in infectious disease management, oncology, and other clinical areas is also contributing to market progression.
|
Analysis Type |
Factors |
Example |
|
Market Drivers |
Strengthening regional distribution and technical capabilities |
In April 2024, altona Diagnostics reorganized subsidiary leadership in Argentina and Brazil, reinforcing its presence across private laboratories, hospitals, and public healthcare institutions. |
|
Market Restraints |
Insufficient laboratory infrastructure and skilled workforce |
Resource-constrained healthcare facilities across Latin America may struggle to implement sophisticated testing procedures, limiting the availability and reach of molecular diagnostic services. |
|
Market Opportunities |
Strategic collaborations to improve molecular testing accuracy |
In December 2025, Microbix Biosystems partnered with Seegene Mexico to support assay validation, laboratory training, and quality assurance for HPV testing. |
The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.
Expanding Diagnostic Networks and Local Expertise to Support Market Value
The expansion of regional operations and strengthening of local expertise are supporting the development of the molecular diagnostics market across Latin America. Established distribution networks, specialized personnel, and stronger customer relationships can improve access to diagnostic technologies across laboratories and healthcare facilities. For instance, in April 2024, Altona Diagnostics announced leadership changes at its subsidiaries in Argentina and Brazil, which serve private laboratories, hospitals, and public healthcare providers. The subsidiaries offer diagnostic products for respiratory diseases, tropical fevers, emerging infections, and transplant testing, supporting regional market development.
Limited Access to Advanced Diagnostic Technologies May Constrain Market Expansion
Uneven access to specialized laboratory infrastructure, trained personnel, and advanced testing technologies can limit the adoption of molecular diagnostics across Latin America. Healthcare facilities with limited resources may face challenges implementing sophisticated testing workflows and maintaining consistent diagnostic capacity. These constraints can delay test availability, restrict adoption outside major urban centers, and increase disparities in access to timely diagnosis. Addressing infrastructure and workforce limitations will be important for expanding molecular diagnostic testing across the region.
Rising Collaborations to Improve Molecular Testing Accuracy Can Expand Market Growth
Collaborations between molecular diagnostics companies and quality assessment providers create opportunities to improve testing accuracy, strengthen laboratory quality management, and expand access to infectious disease diagnostics across Latin America. For instance, in December 2025, Microbix Biosystems Inc. announced a collaboration with Seegene Mexico to support the clinical use of its Allplex and Anyplex molecular multiplex assays for detecting high-risk human papillomavirus (HPV) infections in Mexico. Microbix’s external quality assessment products (QAPs) are intended to support assay validation, laboratory training, and ongoing quality assurance. The collaboration initially focuses on HPV testing, with potential support for respiratory, sexually transmitted, and other infectious disease assays. Such initiatives may strengthen molecular testing reliability and support broader adoption across clinical laboratories.
The market is witnessing trends such as advanced molecular testing, strategic distribution partnerships, and the expansion of innovative infectious disease diagnostics.
Adoption of Advanced Molecular Testing Technologies Is Likely to Support Market Growth
The increasing development of innovative molecular assays is strengthening efforts to improve the accuracy and accessibility of infectious disease diagnosis. Advanced approaches, including CRISPR-based detection and blood-based testing, may help address limitations associated with conventional diagnostic methods. For instance, in June 2026, IntelliGenome announced a partnership with CTR Scientific to support the evaluation and potential commercialization of its CRISPR-TB blood test in Mexico. Such developments could broaden diagnostic options and contribute to the expansion of the market.
Infectious Diseases Likely to Lead the Market Share by Application
The market is segmented by application into oncology, infectious diseases, genetic testing, neurological diseases, cardiovascular diseases, and others. Among these, infectious diseases are expected to represent a leading application, supported by the need for rapid pathogen identification and timely treatment decisions. For instance, in September 2025, Microbio announced a strategic distribution agreement with Abalat to introduce its InfectID-BSI molecular diagnostic platform in Mexico. The test identifies 26 pathogens associated with bloodstream infections and provides results within three hours, supporting demand for faster infectious disease diagnosis. These developments could strengthen the segment's contribution to market growth.
Read more about this report - Request a Free Sample
The regions included in the report are Brazil, Argentina, Mexico, and other Latin American countries. Brazil is expected to maintain a prominent position, supported by its research community, biotechnology activities, and engagement with molecular biology technologies. For instance, in September 2026, Hyasen Biotech announced its participation in Genética 2026, the 71st Brazilian Congress of Genetics, in Florianópolis. The company planned to showcase solutions spanning nucleic acid extraction, PCR, real-time PCR, and next-generation sequencing. Such industry engagement may support collaboration, technology awareness, and the development of molecular diagnostics capabilities, contributing to the country's market growth.
The key features of the market report include funding and investment analysis, and strategic initiatives by leading players. The major companies in the market are as follows:
CEPHEID INC. develops molecular diagnostic solutions, including its GeneXpert® systems, which provide sample-to-answer polymerase chain reaction (PCR) testing. Its portfolio includes the GeneXpert® Infinity, GeneXpert® Xpress, and touchscreen-enabled systems, supporting molecular testing across healthcare settings. The company contributes to the market by offering scalable testing platforms designed to deliver timely, laboratory-quality diagnostic results.
Thermo Fisher Scientific Inc. offers molecular analysis technologies, including the Applied Biosystems QuantStudio Absolute Q Digital PCR System. The platform supports sensitive nucleic acid detection and quantification, including rare mutation analysis, gene expression research, and liquid biopsy applications. Through its digital PCR instruments, assays, and reagents, the company contributes to the market by providing technologies for advanced molecular analysis.
ILLUMINA, INC develops sequencing and genomic analysis technologies that support molecular diagnostics and life science research. Its NovaSeq X Series, including the NovaSeq X and NovaSeq X Plus systems, delivers high-throughput sequencing for applications such as whole-genome sequencing, exome analysis, and circulating tumor DNA sequencing. The company contributes to the Latin America molecular diagnostics market through scalable sequencing platforms and genomic analysis solutions.
Sysmex Corporation develops healthcare diagnostic technologies and laboratory solutions designed to support timely and accurate clinical decisions. Its portfolio includes hematology, urinalysis, and flow cytometry products, supported by customer service and educational resources. The company contributes to the market through its broader diagnostic technology capabilities and regional presence, although the provided information does not specify molecular diagnostic products.
Other key players in the market include F. Hoffmann-La Roche AG, Hologic Inc, BioMérieux SA, Qiagen N.V., Bitgenia S.A., and ABBOTT LABORATORIES.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product and Services
The market is segmented based on the products and services that facilitate molecular testing activities. Increasing laboratory requirements, advances in diagnostic workflows, and the growing integration of molecular methods into healthcare are creating sustained demand for related solutions.
Market Breakup by Test Location
Location-based segmentation considers the different environments through which molecular diagnostic testing is made available. Changes in healthcare delivery, the need for faster diagnostic outcomes, and efforts to improve testing accessibility are shaping the utilization of molecular diagnostic services.
Market Breakup by Technology
The molecular diagnostics market in Latin America is supported by multiple technological approaches designed to provide molecular-level diagnostic information. Improvements in sensitivity, accuracy, automation, and workflow management, together with continuing technological innovation, are encouraging wider implementation across diagnostic and clinical settings.
Market Breakup by Application
Application segmentation reflects the varied purposes for which molecular diagnostics are incorporated into healthcare services in Latin America. Increasing demand for precise diagnosis, improved disease characterization, personalized healthcare approaches, and evidence-based clinical decisions is supporting the expansion of molecular testing applications.
Market Breakup by End User
Molecular diagnostic adoption varies according to the healthcare and diagnostic entities responsible for testing activities. Strengthening diagnostic capabilities, rising testing demand, and increasing integration of molecular solutions into routine healthcare processes are influencing utilization across different end-user categories.
Market Breakup by Country
The market is characterized by expanding healthcare infrastructure, increasing awareness of early disease detection, and growing demand for accurate diagnostic testing. Market growth across individual countries is supported by investments in laboratory capabilities, rising infectious disease testing needs, and the gradual adoption of advanced molecular technologies.
This report is developed through a robust mixed-methods research design combining:
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product and Services |
|
| Breakup by Test Location |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.